Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures:

Karen P Phillips1, Daniel T Walker1, Julie A Humphries1

  • 1HeartCare Partners, GenesisCare, Greenslopes Private Hospital, Newdegate St, Greenslopes, Brisbane, QLD 4120, Australia.

Journal of Arrhythmia
|April 20, 2016
PubMed

Insights

Combined catheter ablation for atrial fibrillation (AF) and left atrial appendage (LAA) occlusion offers a safe, two-pronged approach. This strategy achieved high LAA occlusion rates and reduced stroke risk, allowing oral anticoagulant discontinuation.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) management requires rhythm control and stroke prevention.
  • Concomitant left atrial catheter ablation and left atrial appendage (LAA) occlusion present a dual strategy.
  • This study reports outcomes of combined procedures over a 5-year period.

Purpose of the Study:

  • To evaluate the feasibility and safety of combined AF catheter ablation and LAA device occlusion.
  • To assess the efficacy of this two-pronged strategy for rhythm control and stroke prevention.
  • To analyze procedural outcomes, LAA occlusion rates, and long-term clinical events.

Main Methods:

  • Ninety-eight patients with non-valvular AF underwent pulmonary vein isolation (PVI) followed by Watchman® LAA device implantation.
  • Procedures were performed at a single center over a 5-year timeframe.
  • Outcomes included procedural success, LAA occlusion rates, adverse events, and AF recurrence.

Main Results:

  • Procedures were uncomplicated with a mean duration of 213±40 minutes.
  • Complete LAA occlusion was achieved in 94% initially, reaching 100% at 12 months (86% complete occlusion).
  • One ischemic stroke occurred (0.5% per year), and 77% of patients were free from AF at 12 months; oral anticoagulation was discontinued for all patients.

Conclusions:

  • Combined AF ablation and LAA occlusion is feasible and safe.
  • High rates of LAA occlusion and a low stroke rate were observed.
  • Incomplete occlusion correlated with suboptimal device position and lower compression.
Abstract

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.1K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.3K
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
610